Brought to you by 
Integrated Diagnostics begins operations with $30mm Series A
07 Oct 2020
Executive Summary
Integrated Diagnostics (blood tests using a systems biology approach) has officially started operations and concurrently raised $30mm in its Series A financing from lead investor InterWest Partners, which was joined by the Wellcome Trust and dievini Hopp Biotech. The financing will occur in three tranches, the first of which, totalling $10mm, has been received.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Integrated Diagnostics begins operations with $30mm Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice